n-acetylneuraminic acid and Mucocutaneous Lymph Node Syndrome

n-acetylneuraminic acid has been researched along with Mucocutaneous Lymph Node Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burns, JC; Choudhury, BP; Franco, A; Hibberd, ML; Hoang, LT; Kanda, Y; Kanegaye, JT; Naidu, NN; Ogata, S; Shimizu, C; Touma, R; Tremoulet, AH; Varki, A1

Other Studies

1 other study(ies) available for n-acetylneuraminic acid and Mucocutaneous Lymph Node Syndrome

ArticleYear
Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: B-Lymphocytes; beta-D-Galactoside alpha 2-6-Sialyltransferase; Case-Control Studies; Cell Line; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Female; Fucose; Galactose; Glycosylation; Humans; Immunoglobulins, Intravenous; Male; Mucocutaneous Lymph Node Syndrome; N-Acetylneuraminic Acid; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Sialyltransferases; Solubility; Treatment Outcome

2013